FDA Interim CDER Head Tracy Beth Høeg to Exit Amidst Agency Turnover
Tracy Beth Høeg, the Acting Director of the FDA's Center for Drug Evaluation and Research (CDER), is expected to leave her position, according to Reuters. Høeg, known for her vaccine skepticism, served in the role for about five months and was the fifth person to hold the post since President Trump began his second term. Her departure follows the resignation of former FDA Commissioner Marty Makary, who faced controversies including pressure to approve flavored vapes and criticism over the agency's handling of rare disease decisions. Høeg's exit comes amidst a period of significant turnover at the FDA, with other high-profile departures such as Vinay Prasad, who led the Center for Biologics Evaluation and Research. 
